Intellipharmaceuticals International Inc.
IPCI
IPCI was delisted on the 20th of March, 2019.
0 hedge funds and large institutions have $0 invested in Intellipharmaceuticals International Inc. in 2019 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 12 closing their positions.
100% less funds holding
Funds holding: 12 → 0 (-12)
100% less capital invested
Capital invested by funds: $519K → $0 (-$519K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 12
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$469K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
-$43K |
| 3 |
VF
Virtu Financial
New York
|
-$6K |
| 4 |
Morgan Stanley
New York
|
-$1K |
| 5 |
FDCDDQ
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
|
-$1 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SM
1
Sabby Management
Miami Beach,
Florida
| – | -$469K | -1,944,978 | Closed |
|
|
2
Geode Capital Management
Boston,
Massachusetts
| – | -$43K | -180,877 | Closed |
|
|
VF
3
Virtu Financial
New York
| – | -$6K | -24,949 | Closed |
|
|
4
Morgan Stanley
New York
| – | -$1K | -2,280 | Closed |
|
|
FDCDDQ
5
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
| – | -$1 | -6 | Closed |
|
IPCI Hedge Fund Activity: Q1 2019 in Review
0 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Intellipharmaceuticals International Inc. (IPCI) for Q1 2019, worth a combined $0 — down 100% from $519K a quarter earlier.
Sellers outnumbered buyers: 12 funds closed out of IPCI and 0 opened new positions — a net loss of 12 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Sabby Management, exiting entirely with an estimated $469K sold.
- 0 institutional investors held Intellipharmaceuticals International Inc. (IPCI) as of Q1 2019, down from 12 in Q4 2018.
- Funds reported $0 of Intellipharmaceuticals International Inc. stock for Q1 2019, down 100% quarter-over-quarter.
- 0 funds opened new Intellipharmaceuticals International Inc. positions in Q1 2019 and 12 closed out, a net change of -12 holders.
- The largest Intellipharmaceuticals International Inc. seller in Q1 2019 was Sabby Management, an estimated $469K sold.
Based on aggregated 13F filings for Q1 2019.